Jagsonpal Pharmaceuticals Ltd

NSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Jagsonpal Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
33.96% Fall from 52W High
18.5
TTM PE Ratio
Below industry Median
40
Price to Book Ratio
Above industry Median
4.8
Dividend yield 1yr %
High in industry
1.5
TTM PEG Ratio
PEG TTM is negative
-5.7
RSI
RSI is mid-range
53.3
MFI
MFI is mid-range
61.1

Jagsonpal Pharmaceuticals Ltd shareholding Pattern

Promoter
68.1%
Foreign Institutions
0.7%
Domestic Institutions
0.8%
Public
30.3%
Promoter
68.5%
Foreign Institutions
0.5%
Domestic Institutions
0.8%
Public
30.2%
Promoter
68.7%
Foreign Institutions
0.4%
Domestic Institutions
0.8%
Public
30.1%
Promoter
68.7%
Foreign Institutions
0.4%
Domestic Institutions
0.8%
Public
30.1%
Promoter
68.7%
Foreign Institutions
0.1%
Domestic Institutions
0.8%
Public
30.3%
Promoter
68.7%
Foreign Institutions
0.1%
Domestic Institutions
0.8%
Public
30.4%

Jagsonpal Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
3
5Day EMA
339.70
10Day EMA
338.50
12Day EMA
338.10
20Day EMA
336.70
26Day EMA
335.80
50Day EMA
332.60
100Day EMA
336.00
200Day EMA
347.50
5Day SMA
339.70
10Day SMA
339.80
20Day SMA
334.30
30Day SMA
336.30
50Day SMA
333.50
100Day SMA
320.80
150Day SMA
345.20
200Day SMA
362.90
Delivery & Volume
Resistance & Support
341.18
Pivot
Resistance
First Resistance
344.02
Second Resistance
347.73
Third Resistance
350.57
Support
First Support
337.47
Second support
334.63
Third Support
330.92
Relative Strength Index
53.30
Money Flow Index
61.10
MACD
2.29
MACD Signal
1.82
Average True Range
13.77
Average Directional Index
20.27
Rate of Change (21)
2.45
Rate of Change (125)
-9.83

Jagsonpal Pharmaceuticals Ltd Company background

Founded in: 1978
Managing director: Manish Gupta
Promoted by J S Kochhar in 1978, Jagsonpal Pharmaceuticals is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously it has geared up to set up an ultra modern multipurpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.The company has a strategic alliance with Fidia Spa, Italy and B Spofola, Czechoslovakia to manufacture sophisticated drugs in India. It has tied up with another Israelbased company, Makhteshim Chemical Works, for acquiring the marketing rights of an antioxidant product. In 1994, the company has also promoted Aresco Financial Services, a new financial company.The Companys RD activities have resulted in manufacturing process upgradation, improving packaging, and cost containment. Its RD activities are geared towards development of new product technologies which can be commercialised in future.It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia.In the fiscal 2001, the companys sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds, such as, sluggish market trends, lower growth rate of the industry and severe competition from drug majors. However the company has introduced various measures to counter the above factors so as to achieve continued growth and opportunity.The new manufacturing facility at Pantnagar, Uttarakhand started production in April 2009. The Company launched two brands, Divatrone and ProRetro in the product market segment, Dydrogesterone, which was earlier dominated by a global pharma Company in August, 2021.
Read More

Jagsonpal Pharmaceuticals Ltd FAQs

Jagsonpal Pharmaceuticals Ltd shares are currently priced at 340 on NSE and 339.4 on BSE as of 6/24/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Jagsonpal Pharmaceuticals Ltd [JAGSNPHARM] share was -9.35. The Jagsonpal Pharmaceuticals Ltd [JAGSNPHARM] share hit a 1-year low of Rs. 273.6 and a 1-year high of Rs. 514.85.

The market cap of Jagsonpal Pharmaceuticals Ltd is Rs. 899.68 Cr. as of 6/24/2024 12:00:00 AM.

The PE ratios of Jagsonpal Pharmaceuticals Ltd is 40 as of 6/24/2024 12:00:00 AM.

The PB ratios of Jagsonpal Pharmaceuticals Ltd is 4.79 as of 6/24/2024 12:00:00 AM

You can easily buy Jagsonpal Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage